(TNX-1500) in Kidney Transplant Recipients

NCT07204080 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant
Kidney Transplant Failure and Rejection
Immunosuppression
Immunosuppression After Kidney Transplantation

Interventions

DRUG: TNX-1500
PROCEDURE: Kidney Transplant

Sponsor

Ayman Al Jurdi, MD

Collaborators

Tonix Pharmaceuticals, Inc.